TMCnet News
AI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report FindsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released its 2026 Future Health Index U.S. report, "AI in practice: Shaping the future of healthcare now," revealing how AI is delivering measurable benefits across healthcare systems under growing strain. The report shows AI increasingly embedded into clinical workflows, helping clinicians regain time, improve decision-making, expand patient capacity and reduce administrative burden. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609219865/en/
FHI 2026 US Report Cover Among the key findings from the U.S. report:
Emerging from this year's report is the advent of a new "hybrid care team," where AI supports clinicians and patients while human judgment remains central to care. A majority of clinicians are comfortable with AI supporting decisions as a 'partner' when it comes to diagnostic decision support tools, medical image analysis tools, medical imaging processing systems and surgical guidance systems, amongst others. Importantly, more than 90% say it is essential to keep a human in the loop as AI advances. At the same time, the findings point to ongoing readiness challenges. Nearly eight in 10 healthcare professionals say training for AI-enabled tools is limited or inconsistent at their organization, underscoring the need for stronger infrastructure, workforce readiness and governance as AI adoption accelerates. "The growth in adoption of AI over the last year has been nothing short of remarkable - and healthcare leaders are increasingly seeing an AI dividend. Their investments are giving time back to clinicians and improving the patient experience," said Jeff DiLullo, Chief Region Leader, Philips North America. "We're still in the early days of this transformation. To realize these benefits across the broader healthcare ecosystem and have impact at scale, AI must be embedded seamlessly into clinical workflows and supported by consistent education and training." About the Future Health Index 2026 The Future Health Index is the largest global survey of its kind, analyzing the perspectives of healthcare professionals and patients across multiple countries. Based on proprietary quantitative research involving over 2,000 healthcare professionals and more than 20,000 patients across 10 countries, the 2026 edition examines how AI is actively being used across healthcare systems and the value it creates in time regained, expanded capacity and improvements in care delivery. For more information, or to download the full U.S. report, visit www.usa.philips.com/futurehealthindex-2026. About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260609219865/en/ |

